The quest of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): searching for evidence

被引:0
|
作者
Reymond, Marc A. [1 ]
机构
[1] Univ Hosp, Dept Surg & Transplantat, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
关键词
D O I
10.1515/pap-2016-0026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:167 / 168
页数:2
相关论文
共 50 条
  • [41] Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
    Nunez, Maria F.
    Sardi, Armando
    Nieroda, Carol
    Jimenez, William
    Sittig, Michelle
    MacDonald, Ryan
    Aydin, Nail
    Milovanov, Vladimir
    Gushchin, Vadim
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1658 - 1663
  • [42] Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Elderly
    Votanopoulos, K. I.
    Shen, P.
    Stewart, J. H.
    Russell, G.
    Levine, E. A.
    Newman, N. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S100 - S101
  • [43] Complications after cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy (HIPEC)
    Eshmuminov, D.
    Kranzbuehler, B.
    Slankamenac, K.
    Vandoni, R.
    Clavien, P. -A.
    Vonlanthen, R.
    Lehmann, K.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 4 - 4
  • [44] Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
    Maria F. Nunez
    Armando Sardi
    Carol Nieroda
    William Jimenez
    Michelle Sittig
    Ryan MacDonald
    Nail Aydin
    Vladimir Milovanov
    Vadim Gushchin
    Annals of Surgical Oncology, 2015, 22 : 1658 - 1663
  • [45] The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Tan, Grace Hwei Ching
    Shannon, Nicholas B.
    Chia, Claramae Shulyn
    Lee, Lui Shiong
    Soo, Khee Chee
    Teo, Melissa Ching Ching
    ASIAN JOURNAL OF UROLOGY, 2018, 5 (03) : 194 - 198
  • [46] Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Votanopoulos, Konstantinos I.
    Randle, Reese W.
    Craven, Brandon
    Swett, Katrina R.
    Levine, Edward A.
    Shen, Perry
    Stewart, John H.
    Mirzazadeh, Majid
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 868 - 874
  • [47] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation
    B. Noiret
    G. Piessen
    C. Eveno
    Annals of Surgical Oncology, 2021, 28 : 5448 - 5449
  • [48] Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Stockley, Cecily
    Bouchard-Fortier, Antoine
    Mateshaytis, Jennifer
    Taqi, Kadhim
    Mack, Lloyd
    Nelson, Gregg
    Chong, Michael
    Deban, Melina
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [49] Viscoelastic Coagulation Monitoring in Patient Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Case Study
    Kovac, Natasa
    Radocaj, Tomislav
    Pazur, Iva
    Perisa, Nikola
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 2177 - 2178
  • [50] Value-Based Health Care: The Fine Balance of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS ± HIPEC)
    Jessica Bogach
    Allison Maciver
    Valerie A. Francescutti
    Annals of Surgical Oncology, 2023, 30 : 7926 - 7928